Liquidia Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于公司

公司简介

公司代码LQDA

公司名称Liquidia Corp

上市日期Jul 26, 2018

CEODr. Roger A. Jeffs, Ph.D.

员工数量157

证券类型Ordinary Share

年结日Jul 26

公司地址419 Davis Drive

城市MORRISVILLE

上市交易所NASDAQ Capital Market Consolidated

国家United States of America

邮编27560

电话19193284400

网址https://www.liquidia.com/

公司代码LQDA

上市日期Jul 26, 2018

CEODr. Roger A. Jeffs, Ph.D.

公司高管

名称

名称/职务

职务

持股

持股变动

Dr. Roger A. Jeffs, Ph.D.

Chief Executive Officer, Director

2.12M

-0.30%

Mr. Russell Schundler, J.D.

General Counsel, Secretary

369.92K

-0.29%

Mr. Rajeev Saggar, M.D.

Chief Medical Officer

242.60K

-7.62%

Mr. Scott Moomaw

Chief Commercial Officer

145.57K

-32.69%

Mr. Jason Adair

Chief Business Officer

140.33K

-0.32%

Mr. Michael Kaseta

Chief Financial Officer, Chief Operating Officer

91.78K

-1.24%

Mr. Damian Degoa

Independent Director

66.11K

+38.55%

Mr. Arthur S. Kirsch

Independent Director

50.40K

+57.49%

Ms. Katherine (Katie) Rielly-Gauvin

Independent Director

18.40K

--

Dr. Joanna C. Horobin

Independent Director

13.40K

-27.18%

名称

名称/职务

职务

持股

持股变动

Dr. Roger A. Jeffs, Ph.D.

Chief Executive Officer, Director

2.12M

-0.30%

Mr. Russell Schundler, J.D.

General Counsel, Secretary

369.92K

-0.29%

Mr. Rajeev Saggar, M.D.

Chief Medical Officer

242.60K

-7.62%

Mr. Scott Moomaw

Chief Commercial Officer

145.57K

-32.69%

Mr. Jason Adair

Chief Business Officer

140.33K

-0.32%

Mr. Michael Kaseta

Chief Financial Officer, Chief Operating Officer

91.78K

-1.24%

收入明细

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

暂无数据

地区USD

名称

营收

占比

United States

14.00M

0.00%

业务

地区

暂无数据

股东统计

更新时间: 8月16日周六

持股股东

股东类型

持股股东

占比

Caligan Partners, LP

9.43%

Farallon Capital Management, L.L.C.

7.94%

Manning (Paul B.)

7.21%

BlackRock Institutional Trust Company, N.A.

4.95%

The Vanguard Group, Inc.

4.16%

其他

66.31%

持股股东

占比

Caligan Partners, LP

9.43%

Farallon Capital Management, L.L.C.

7.94%

Manning (Paul B.)

7.21%

BlackRock Institutional Trust Company, N.A.

4.95%

The Vanguard Group, Inc.

4.16%

其他

66.31%

股东类型

持股股东

占比

Hedge Fund

36.23%

Investment Advisor

15.90%

Investment Advisor/Hedge Fund

12.18%

Individual Investor

11.46%

Research Firm

4.24%

Corporation

2.67%

Private Equity

1.28%

Bank and Trust

0.45%

Pension Fund

0.18%

其他

15.42%

机构持股

更新时间: 7月1日周二

报告期

机构数

持股数

持股占比

持股变动

2025Q2

350

67.92M

79.46%

-5.32M

2025Q1

356

67.75M

79.47%

-4.91M

2024Q4

344

63.62M

75.17%

-10.09M

2024Q3

335

73.31M

89.39%

+16.42M

2024Q2

318

66.67M

87.88%

+4.98M

2024Q1

302

59.34M

79.61%

+7.64M

2023Q4

256

48.15M

70.41%

+4.56M

2023Q3

236

40.52M

62.49%

-5.87M

2023Q2

223

41.12M

63.56%

-6.16M

2023Q1

214

42.01M

65.00%

-5.41M

股东持股明细

名称

持股数

占比

持股变动

变动比例

公告日期

Caligan Partners, LP

8.12M

9.5%

--

Apr 23, 2025

Farallon Capital Management, L.L.C.

3.99M

4.67%

+700.00K

+21.27%

Mar 31, 2025

Manning (Paul B.)

6.16M

7.21%

+18.40K

+0.30%

Jun 17, 2025

BlackRock Institutional Trust Company, N.A.

4.20M

4.91%

+14.68K

+0.35%

Mar 31, 2025

The Vanguard Group, Inc.

3.45M

4.04%

-94.77K

-2.67%

Mar 31, 2025

Findell Capital Management LLC

2.89M

3.38%

-190.00K

-6.17%

Mar 31, 2025

Opaleye Management Inc.

2.26M

2.64%

+561.86K

+33.09%

Mar 31, 2025

Goldman Sachs & Company, Inc.

779.12K

0.91%

+70.88K

+10.01%

Mar 31, 2025

Jeffs (Roger A)

2.13M

2.49%

+38.56K

+1.85%

Jun 04, 2025

Legend Aggregator LP

1.86M

2.18%

-5.32M

-74.10%

Dec 31, 2024

持股ETF

更新时间: 9月2日周二

机构名称

占比

SPDR S&P Pharmaceuticals ETF

2.16%

Virtus LifeSci Biotech Clinical Trials ETF

1.53%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.34%

iShares U.S. Pharmaceuticals ETF

0.44%

iShares Micro-Cap ETF

0.27%

SPDR S&P Kensho New Economies Composite ETF

0.24%

Vanguard US Momentum Factor ETF

0.11%

iShares Russell 2000 Growth ETF

0.08%

Proshares Ultra Russell 2000

0.05%

ProShares UltraPro Russell2000

0.05%

SPDR S&P Pharmaceuticals ETF

占比2.16%

Virtus LifeSci Biotech Clinical Trials ETF

占比1.53%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

占比1.34%

iShares U.S. Pharmaceuticals ETF

占比0.44%

iShares Micro-Cap ETF

占比0.27%

SPDR S&P Kensho New Economies Composite ETF

占比0.24%

Vanguard US Momentum Factor ETF

占比0.11%

iShares Russell 2000 Growth ETF

占比0.08%

Proshares Ultra Russell 2000

占比0.05%

ProShares UltraPro Russell2000

占比0.05%

分红派息

近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股

公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

Liquidia Corp

21.800USD

Liquidia Corp

21.800

概览

公司

财务

分析